Immucell (ICCC) Total Debt Growth (1y) (2011 - 2026)
Powered by 
Analysis
Immucell (ICCC) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | -20.41% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 37.49% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -6.91% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -2.36% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 0.11% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | -12.53% |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -55.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.11% |
| Dec 31, 2025 | -13.66% |
| Sep 30, 2025 | 1.65% |
| Jun 30, 2025 | -12.97% |
| Mar 31, 2025 | 1.28% |
| Dec 31, 2024 | -11.95% |
| Sep 30, 2024 | -20.58% |
| Jun 30, 2024 | 15.71% |
| Mar 31, 2024 | 16.35% |
| Dec 31, 2023 | 17.00% |
| Sep 30, 2023 | 31.02% |
| Jun 30, 2023 | -9.04% |
| Mar 31, 2023 | -8.64% |
| Dec 31, 2022 | 11.94% |
| Sep 30, 2022 | 12.26% |
| Jun 30, 2022 | 17.27% |
| Mar 31, 2022 | 17.33% |
| Dec 31, 2021 | -3.77% |
| Sep 30, 2021 | -3.95% |
| Jun 30, 2021 | -7.46% |